Role of the Serine-Rich Surface Glycoprotein Srr1 of Streptococcus agalactiae in the Pathogenesis of Infective Endocarditis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Seo, Ho Seong ^a   Xiong, Yan Q ^b,c   Sullam, Paul M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN G; SERINE RICH REPEAT 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CONTROLLED STUDY; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VITRO STUDY; KIDNEY PARENCHYMA; MIXED INFECTION; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPLEEN; STREPTOCOCCUS AGALACTIAE; THROMBOCYTE; VEGETATION; WILD TYPE;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL ADHESION; BLOOD PLATELETS; ENDOCARDITIS, BACTERIAL; FEMALE; FIBRINOGEN; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 84878120108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064204     Document Type: Article

References (52)

1. Sunkara B, Bheemreddy S, Lorber B, Lephart PR, Hayakawa K, et al. (2012) Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression. Int J Infect Dis 16: e182-186.
2. Farley MM, (2001) Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33: 556-561.
3. Munoz P, Llancaqueo A, Rodriguez-Creixems M, Pelaez T, Martin L, et al. (1997) Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 157: 213-216.
4. Siciliano RF, Cais DP, Navarro RC, Strabelli TM, (2010) Acute Streptococcus agalactiae endocarditis: outcomes of early surgical treatment. Heart Lung 39: 331-334.
5. Ivanova Georgieva R, Garcia Lopez MV, Ruiz-Morales J, Martinez-Marcos FJ, Lomas JM, et al. (2010) Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Infect 61: 54-59.
6. Rollan MJ, San Roman JA, Vilacosta I, Sarria C, Lopez J, et al. (2003) Clinical profile of Streptococcus agalactiae native valve endocarditis. Am Heart J 146: 1095-1098.
7. Sambola A, Miro JM, Tornos MP, Almirante B, Moreno-Torrico A, et al. (2002) Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998. Clin Infect Dis 34: 1576-1584.
8. Kannan R, Komaranchath AM, Mathew T, Ramprakash B, Sundararaman T, et al. (2001) Streptococcus agalactiae endocarditis. J Assoc Physicians India 49: 1125-1126.
9. Fitzgerald JR, Loughman A, Keane F, Brennan M, Knobel M, et al. (2006) Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol 59: 212-230.
10. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, et al. (2005) Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 57: 804-818.
11. Fitzgerald JR, Foster TJ, Cox D, (2006) The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 4: 445-457.
12. Moreillon P, Que YA, Bayer AS, (2002) Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 16: 297-318.
13. Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, et al. (2012) Use of a Human-like Low-grade Bacteremia Model of Experimental Endocarditis to Study the Role of Staphylococcus aureus Adhesins and Platelet Aggregation in Early Endocarditis. Infect Immun 81 (3) (): 697-703.
14. Zhou M, Wu H, (2009) Glycosylation and biogenesis of a family of serine-rich bacterial adhesins. Microbiology 155: 317-327.
15. Bensing BA, Lopez JA, Sullam PM, (2004) The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha. Infect Immun 72: 6528-6537.
16. Lizcano A, Sanchez CJ, Orihuela CJ, (2012) A role for glycosylated serine-rich repeat proteins in gram-positive bacterial pathogenesis. Mol Oral Microbiol 27: 257-269.
17. Siboo IR, Chambers HF, Sullam PM, (2005) Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect Immun 73: 2273-2280.
18. Heilmann C, Niemann S, Sinha B, Herrmann M, Kehrel BE, et al. (2004) Staphylococcus aureus fibronectin-binding protein (FnBP)-mediated adherence to platelets, and aggregation of platelets induced by FnBPA but not by FnBPB. J Infect Dis 190: 321-329.
19. Miajlovic H, Loughman A, Brennan M, Cox D, Foster TJ, (2007) Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. Infect Immun 75: 3335-3343.
20. Pietrocola G, Schubert A, Visai L, Torti M, Fitzgerald JR, et al. (2005) FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood 105: 1052-1059.
21. Tazi A, Bellais S, Tardieux I, Dramsi S, Trieu-Cuot P, et al. (2012) Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr Opin Microbiol 15: 44-49.
22. Mistou MY, Dramsi S, Brega S, Poyart C, Trieu-Cuot P, (2009) Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J Bacteriol 191: 4195-4206.
23. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, et al. (2009) The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis 199: 1479-1487.
24. Seifert KN, Adderson EE, Whiting AA, Bohnsack JF, Crowley PJ, et al. (2006) A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 152: 1029-1040.
25. Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, et al. (2011) Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol 193: 6834-6842.
26. Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM, (2012) Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the eevelopment of meningitis. PLoS Pathog 8: e1002947.
27. Seo HS, Xiong YQ, Mitchell J, Seepersaud R, Bayer AS, et al. (2010) Bacteriophage lysin mediates the binding of Streptococcus mitis to human platelets through interaction with fibrinogen. PLoS Pathog 6: e1001047.
28. Seo HS, Sullam PM, (2011) Characterization of the fibrinogen binding domain of bacteriophage lysin from Streptococcus mitis. Infect Immun 79: 3518-3526.
29. Xiong YQ, Bensing BA, Bayer AS, Chambers HF, Sullam PM, (2008) Role of the serine-rich surface glycoprotein GspB of Streptococcus gordonii in the pathogenesis of infective endocarditis. Microb Pathog 45: 297-301.
30. Mitchell J, Siboo IR, Takamatsu D, Chambers HF, Sullam PM, (2007) Mechanism of cell surface expression of the Streptococcus mitis platelet binding proteins PblA and PblB. Mol Microbiol 64: 844-857.
31. Mitchell J, Sullam PM, (2009) Streptococcus mitis phage-encoded adhesins mediate attachment to α2-8-linked sialic acid residues on platelet membrane gangliosides. Infect Immun 77: 3485-3490.
32. Que YA, Moreillon P, (2011) Infective endocarditis. Nat Rev Cardiol 8: 322-336.
33. Geoghegan JA, Ganesh VK, Smeds E, Liang X, Hook M, et al. (2009) Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen. J Biol Chem 285: 6208-6216.
34. Shannon O, Flock JI, (2004) Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibits platelet aggregation. Thromb Haemost 91: 779-789.
35. Ganesh VK, Barbu EM, Deivanayagam CC, Le B, Anderson AS, et al. (2011) Structural and biochemical characterization of Staphylococcus aureus clumping factor B/ligand interactions. J Biol Chem 286: 25963-25972.
36. Sillanpaa J, Nallapareddy SR, Houston J, Ganesh VK, Bourgogne A, et al. (2009) A family of fibrinogen-binding MSCRAMMs from Enterococcus faecalis. Microbiology 155: 2390-2400.
37. Devi AS, Ponnuraj K, (2010) Cloning, expression, purification and ligand binding studies of novel fibrinogen-binding protein FbsB of Streptococcus agalactiae. Protein Expr Purif 74: 148-155.
38. Pietrocola G, Visai L, Valtulina V, Vignati E, Rindi S, et al. (2006) Multiple interactions of FbsA, a surface protein from Streptococcus agalactiae, with fibrinogen: affinity, stoichiometry, and structural characterization. Biochemistry 45: 12840-12852.
39. Xiang H, Feng Y, Wang J, Liu B, Chen Y, et al. (2012) Crystal structures reveal the multi-ligand binding mechanism of Staphylococcus aureus ClfB. PLoS Pathog 8: e1002751.
40. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penades J, et al. (2002) Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 44: 1033-1044.
41. Sullam PM, Valone FH, Mills J, (1987) Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun 55: 1743-1750.
42. Widmer E, Que YA, Entenza JM, Moreillon P, (2006) New concepts in the pathophysiology of infective endocarditis. Curr Infect Dis Rep 8: 271-279.
43. Moreillon P, Que YA, (2004) Infective endocarditis. Lancet 363: 139-149.
44. Nobbs AH, Lamont RJ, Jenkinson HF, (2009) Streptococcus adherence and colonization. Microbiol Mol Biol Rev 73: 407-450.
45. Santoro J, Levison ME, (1978) Rat model of experimental endocarditis. Infect Immun 19: 915-918.
46. Sullam PM, Bayer AS, Foss WM, Cheung AL, (1996) Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun 64: 4915-4921.
47. Xiong YQ, Fowler VG, Yeaman MR, Perdreau-Remington F, Kreiswirth BN, et al. (2009) Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. J Infect Dis 199: 201-208.
48. Piroth L, Que YA, Widmer E, Panchaud A, Piu S, et al. (2008) The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect Immun 76: 3824-3831.
49. Que YA, Haefliger JA, Piroth L, Francois P, Widmer E, et al. (2005) Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 201: 1627-1635.
50. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, et al. (1995) Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63: 4738-4743.
51. Wessels MR, Haft RF, Heggen LM, Rubens CE, (1992) Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun 60: 392-400.
52. Wilkinson HW, (1977) Nontypable group B streptococci isolated from human sources. J Clin Microbiol 6: 183-184.